The Zhitong Finance App learned that UBS released a research report stating that it will raise China Life's (02628.HK) 2026 net profit forecast by 37% to reflect the profit forecast for the first half of the year and the macro environment for the second half of the year to date. UBS reiterated its “buy” rating for China Life, and the target price for H shares remained unchanged at HK$40.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.